Cardica, Inc. engages in the design, manufacture, and marketing of automated anastomotic systems for use by cardiac surgeons to perform coronary bypass surgery in the United States and internationally. It provides C-Port Distal Anastomosis systems, including C-Port xA Anastomosis systems to perform an end-to-side distal anastomosis by attaching the end of a bypass graft to a coronary artery downstream of an occlusion or narrowing; C-Port Flex A Anastomosis systems to enable automated anastomoses to be performed as part of coronary artery bypass grafting procedures; and PAS-Port Proximal Anastomosis systems to perform an end-to-side proximal anastomosis between a saphenous vein and the aorta. The company markets its Port Distal Anastomosis systems through its direct sales force, as well as through independent manufacturers’ representatives and distributors. It is also involved in the development of endoscopic microcutter products comprising MicroCutter XCHANGE 30, a cartridge based microcutter device; MicroCutter XCHANGE 45, a planned cartridge based microcutter device; MicroCutter XPRESS 30, the true multi-fire endolinear stapling device; MicroCutter FLEXCHANGE 30 a planned cartridge based microcutter device to facilitate endoscopic procedures requiring cutting and stapling; MicroCutter XPRESS 45, a planned multi-fire endolinear microcutter device; and MicroCutter XPRESS 60, a planned cutting and stapling device for the bariatric and thoracic surgery markets. In addition, the company licenses its intellectual property in the robotics field in diagnostic or therapeutic medical procedures. The company was formerly known as Vascular Innovations, Inc. and changed its name to Cardica, Inc. in November 2001. Cardica, Inc. was founded in 1997 and is headquartered in Redwood City, California.

Key Statistics